10-Q/A: Damon Inc. Restates Quarterly Report Due to $2.3 Million Accounting Error

Sentiment:

Quarterly Report Amendment


Damon Inc. files an amended quarterly report to correct a $2.3 million understatement of transaction costs related to a business combination.

Capital raiseThe Company agreed to issue and sell to Streeterville one or more pre-paid purchases at an aggregate purchase price of up to $10,000,000 for the purchase of the Company's common shares.Effective January 7, 2025, we entered into a Financial Advisory Agreement with Maxim Group LLC to provide advisory services to the Company, including consultation on capital raising matters such as a private placement of equity or equity-linked securities.
Worse than expectedThe company is restating its financials due to a material accounting error.The company identified material weaknesses in its internal control over financial reporting.

Summary

  • Damon Inc. is filing an amendment to its quarterly report on Form 10-Q/A for the period ended December 31, 2024.
  • The amendment addresses a restatement of the company's unaudited condensed financial statements.
  • The restatement corrects an accounting error where transaction costs related to a business combination were understated by $2.3 million.
  • The error stemmed from the omission of previously settled fees owed to a former financial advisor.
  • The understated cost impacted financial statement line items for the three and six months ended December 31, 2024.
  • The restatement does not affect the company's cash position or revenues for the three and six months ended December 31, 2024.
  • The audit committee concluded that the original financial statements should no longer be relied upon.
  • The amended report includes revised financial statements, management's discussion and analysis, and certifications from the CEO and CFO.
  • The company had 22,030,884 common shares outstanding as of February 13, 2025.

Sentiment

Score: 4

Explanation: The document highlights a material weakness in internal controls and a restatement, which is negative. However, the company is taking steps to correct the issue and has secured additional financing.

Positives

  • The restatement does not have an impact on the company's cash position or revenues for the three and six months ended December 31, 2024.
  • The company is taking steps to correct the error and improve its financial reporting.

Negatives

  • The company's previously issued financial statements for the three and six months ended December 31, 2024, should no longer be relied upon.
  • The company identified material weaknesses in its internal control over financial reporting.

Risks

  • The company has a history of operating losses and there is no assurance that we will be able to achieve profitability, raise additional financing or continue as a going concern.
  • The company has identified material weaknesses in its internal control over financial reporting.
  • The company may lose its foreign private issuer status in the future, which could result in significant additional costs and expenses and may impede our ability to maintain our listing on Nasdaq.
  • The company's common shares are listed on Nasdaq, but we cannot guarantee that we will be able to satisfy the applicable listing standards going forward.

Future Outlook

The company expects to continue to make significant expenditures to expand its business and develop manufacturing operations in the future, and may continue to incur operating losses and have negative cash flows in the short term.

Management Comments

  • Management noted an accounting error where the transaction cost incurred in connection with the Business Combination was understated by $2,300,000 for the three and six months ended December 31, 2024.

Industry Context

The company is operating in the electric vehicle and scientific software industries, both of which are subject to rapid technological change and increasing competition.

Comparison to Industry Standards

  • The document does not provide enough information to make a detailed comparison to industry standards.
  • A full analysis would require benchmarking against competitors like Zero Motorcycles (electric motorcycles) and companies offering similar scientific software solutions.

Stakeholder Impact

  • Shareholders may experience a decrease in confidence due to the restatement and identified material weaknesses.
  • The restatement could affect the company's ability to raise capital in the future.

Next Steps

  • The company intends to monitor its MVLS between now and July 7, 2025, and may, if appropriate, evaluate available options to resolve the deficiency under the MVLS Requirement and regain compliance with the MVLS Requirement.
  • The company intends to monitor the closing price of its common shares between now and July 21, 2025, and may, if appropriate, evaluate available options to resolve the deficiency and regain compliance with the Bid Price Rule including effecting a reverse stock split.
  • Management is currently completing the formal documentation for the design and implementation of the of the internal control systems and will perform testing.

Key Dates

DateDescription
October 17, 2023Damon Inc. (formerly Grafiti Holding Inc.) was originally incorporated in British Columbia, Canada.
December 27, 2023The record date for the spin-off of Damon Inc. by XTI Aerospace Inc.
November 12, 2024Effectiveness of Damon Inc.'s registration statement on Form 10-12B.
November 13, 2024Completion of the business combination transaction with Damon Motors Inc.
February 14, 2025Original filing date of the Quarterly Report on Form 10-Q for the period ended December 31, 2024.
February 13, 2025Date as of which there were 22,030,884 common shares issued and outstanding.
March 14, 2025Date of amended filing of the Quarterly Report on Form 10-Q/A.

Keywords

restatement, financial statements, transaction costs, business combination, accounting error, Damon Inc., Form 10-Q/A

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.